Quantum Biopharma annual capital expenditures (capex)
2020
2021
2022
2023
2024
Quantum Biopharma Capital Expenditures (CapEx) Growth & History (QNTM)
Quantum Biopharma's capital expenditures (capex) was $0 for fiscal 2024.
View full Quantum Biopharma company overviewQuantum Biopharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | −$113,958 | — |
| 2022 | 2022-12-31 | $113,958 | $113,958 | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | — | — |
Quantum Biopharma capital expenditures (capex) trends
Between the periods ended 2020-12-31 and 2024-12-31, Quantum Biopharma's capital expenditures (capex) increased from $0 to $0, a change of $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quantum Biopharma source filings ↗